<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
NBIX
Neurocrine
$
()


  • Tesla, Airbnb upgraded: Wall Street's top analyst calls

    4/24/2024 - 09:36am
  • Wells Fargo upgrades Neurocrine with pipeline 'turning a corner'

    4/23/2024 - 16:41pm
  • Wells Fargo gets more bullish on Neurocrine, upgrades shares

    4/23/2024 - 16:09pm
  • Neurocrine NBI-1065845 results 'look potentially promising,' says RBC Capital

    4/23/2024 - 10:29am
  • Neurocrine's NBI-1065845 shows efficacy in major depressive disorder

    4/23/2024 - 07:08am
  • Neurocrine, Sentia Medical Sciences extend CRF research collaboration

    4/16/2024 - 16:11pm
  • Voyager announces selection of development candidate for GBA1 Program

    4/16/2024 - 07:06am
  • Neurocrine initiates Phase 1 study of NBI-1065890

    3/28/2024 - 08:31am
  • Neurocrine price target raised by $10 at JPMorgan, here's why

    3/20/2024 - 07:03am
  • Spruce Biosciences just downgraded at Leerink, here's why

    3/14/2024 - 06:16am
  • Neurocrine price target raised by $30 at Oppenheimer, here's why

    3/13/2024 - 07:23am
  • Voyager Therapeutics reports selection of gene therapy development candidate

    2/26/2024 - 07:16am
  • JPMorgan biotech analysts to hold an analyst/industry conference call

    2/23/2024 - 11:55am
  • JPMorgan biotech analysts to hold an analyst/industry conference call

    2/23/2024 - 11:00am
  • Neurocrine price target raised by $31 at UBS, here's why

    2/20/2024 - 07:31am
dynamic_feed Breaking News